隴神戎發(300534.SZ):公司回款情況良好
格隆匯7月27日丨有投資者向隴神戎發(300534.SZ)提問:公司應收賬款不斷上升的原因是什麼,如何看待未來的回款情況?
隴神戎發回復:應收賬款增長原因主要是受公司主打品種市場銷售增長等影響,普安製藥主打產品宣肺止嗽合劑和隴神戎發主打產品元胡止痛滴丸2022年以來營業收入同比大幅增加,應收賬款也因此上升。公司回款情況良好,未來公司將加強貨款催收,持續改善應收賬款的賬齡結構,進一步降低迴款風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.